Robert Langer Rejoins the Board
September 3, 2025We are pleased to announce that Robert Langer, Sc.D., has rejoined the Board of Directors of Combined Therapeutics in August 2025. His guidance and expertise will continue to be invaluable as we advance our technology and partnerships.